A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults.
Condition: Pneumococcal Disease Interventions: Other: Low dose multivalent pneumococcal conjugate vaccine formulation A; Other: Low dose multivalent pneumococcal conjugate vaccine formulation B; Biological: Low dose of multivalent pneumococcal conjugate vaccine control; Biological: Standard dose multivalent pneumococcal conjugate va ccine control Sponsor: Pfizer Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Learning | Meningitis Vaccine | Pfizer | Pneomococcal Vaccine | Research | Study | Universities & Medical Training | Vaccines